| Memantine for the treatment of dementia: a review on its current and future applications J Folch, O Busquets, M Ettcheto, E Sánchez-López, RD Castro-Torres, ... Journal of Alzheimer's Disease 62 (3), 1223-1240, 2018 | 262 | 2018 |
| Long-term exposition to a high fat diet favors the appearance of β-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer’s disease O Busquets, M Ettcheto, M Pallàs, C Beas-Zarate, E Verdaguer, ... Mechanisms of ageing and development 162, 38-45, 2017 | 111 | 2017 |
| ADAM10 in Alzheimer's disease: Pharmacological modulation by natural compounds and its role as a peripheral marker PR Manzine, M Ettcheto, A Cano, O Busquets, E Marcello, S Pelucchi, ... Biomedicine & Pharmacotherapy 113, 108661, 2019 | 82 | 2019 |
| Benzodiazepines and related drugs as a risk factor in Alzheimer's disease dementia M Ettcheto, J Olloquequi, E Sanchez-Lopez, O Busquets, A Cano, ... Frontiers in aging neuroscience 11, 344, 2020 | 63 | 2020 |
| The implication of the brain insulin receptor in late onset Alzheimer’s disease dementia J Folch, M Ettcheto, O Busquets, E Sanchez-Lopez, RD Castro-Torres, ... Pharmaceuticals 11 (1), 11, 2018 | 61 | 2018 |
| Epigallocatechin-3-Gallate (EGCG) improves cognitive deficits aggravated by an obesogenic diet through modulation of unfolded protein response in APPswe/PS1dE9 mice M Ettcheto, A Cano, PR Manzine, O Busquets, E Verdaguer, ... Molecular neurobiology 57, 1814-1827, 2020 | 60 | 2020 |
| The involvement of peripheral and brain insulin resistance in late onset Alzheimer’s dementia J Folch, J Olloquequi, M Ettcheto, O Busquets, E Sanchez-Lopez, A Cano, ... Frontiers in aging neuroscience 11, 236, 2019 | 59 | 2019 |
| Experimental models for aging and their potential for novel drug discovery J Folch, O Busquets, M Ettcheto, E Sánchez-López, M Pallàs, ... Current Neuropharmacology 16 (10), 1466-1483, 2018 | 51 | 2018 |
| Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways M Ettcheto, E Sánchez-López, L Pons, O Busquets, J Olloquequi, ... Redox biology 13, 345-352, 2017 | 40 | 2017 |
| JNK isoforms are involved in the control of adult hippocampal neurogenesis in mice, both in physiological conditions and in an experimental model of temporal lobe epilepsy RD Castro-Torres, J Landa, M Rabaza, O Busquets, J Olloquequi, ... Molecular Neurobiology 56, 5856-5865, 2019 | 33 | 2019 |
| Early preclinical changes in hippocampal CREB-binding protein expression in a mouse model of familial Alzheimer’s disease M Ettcheto, S Abad, D Petrov, I Pedrós, O Busquets, E Sánchez-López, ... Molecular neurobiology 55, 4885-4895, 2018 | 29 | 2018 |
| JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid O Busquets, M Ettcheto, E Verdaguer, RD Castro-Torres, C Auladell, ... Neuropharmacology 131, 440-452, 2018 | 29 | 2018 |
| Peripheral and central effects of memantine in a mixed preclinical mice model of obesity and familial Alzheimer’s disease M Ettcheto, E Sánchez-López, Y Gómez-Mínguez, H Cabrera, O Busquets, ... Molecular Neurobiology 55, 7327-7339, 2018 | 28 | 2018 |
| Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration C Auladell, L de Lemos, E Verdaguer, M Ettcheto, O Busquets, ... Front Biosci (Landmark Ed) 22, 795-814, 2017 | 26 | 2017 |
| A metabolic perspective of late onset Alzheimer’s disease M Ettcheto, A Cano, O Busquets, PR Manzine, E Sanchez-Lopez, ... Pharmacological Research 145, 104255, 2019 | 25 | 2019 |
| Role of c-Jun N-Terminal Kinases (JNKs) in epilepsy and metabolic cognitive impairment O Busquets, M Ettcheto, A Cano, P R. Manzine, E Sanchez-Lopez, ... International Journal of Molecular Sciences 21 (1), 255, 2019 | 22 | 2019 |
| Anti-inflammatory role of Leptin in glial cells through p38 MAPK pathway inhibition I Patraca, N Martínez, O Busquets, A Martí, I Pedrós, C Beas-Zarate, ... Pharmacological Reports 69 (3), 409-418, 2017 | 20 | 2017 |
| Pharmacological strategies to improve dendritic spines in Alzheimer’s disease M Ettcheto, O Busquets, A Cano, E Sanchez-Lopez, PR Manzine, ... Journal of Alzheimer's Disease 82 (s1), S91-S107, 2021 | 19 | 2021 |
| Dysregulation of insulin-linked metabolic pathways in Alzheimer’s disease: Co-factor role of apolipoprotein E ɛ4 J Robbins, O Busquets, M Tong, SM de la Monte Journal of Alzheimer's Disease Reports 4 (1), 479-493, 2020 | 18 | 2020 |
| A chronological review of potential disease-modifying therapeutic strategies for alzheimer's disease M Ettcheto, O Busquets, T Espinosa-Jiménez, E Verdaguer, C Auladell, ... Current Pharmaceutical Design 26 (12), 1286-1299, 2020 | 14 | 2020 |
Antoni CaminsUniversity of BarcelonaEmail verificata su ub.edu